■
農藥一路發20071期
(2001/10/02) 主編: 方麗萍 www.ag168.com
主題: 拜耳已同意收購安萬特作物保護科技
2001年10月2日安萬特在其法國Strasbourg總部宣佈安萬特及先靈已正式與拜耳簽署收購安萬特作物保護科技之合約.
該公司之股份分別由安萬特及先靈持股76%及24%.
安萬特共值72.5億歐元,
並定於2002年第一季完成交接手續.
拜耳收購安萬特作物保護科技即成為世界農藥界領導者之一,
安萬特深信在策略上拜耳是最適合的人選.
安萬特作物保護科技部門於2000年之營業額為40億歐元,
員工共計15,300人, 分佈在120個國家.
而整個安萬特集團,
包括西藥及農藥之營業額為223億歐元,
員工共計92,500人. 未來安萬特將集中其發展於西藥事業上.
安萬特今天發佈之新聞稿附錄如下:
10-02-01 Aventis
SA Press Release
Bayer agrees to acquire Aventis CropScience
Strasbourg, France - Aventis and Schering AG have signed an agreement with
Bayer AG on the acquisition of Aventis CropScience. Aventis holds a 76
percent interest in this business, while Schering AG, Berlin, holds 24
percent.
Under the terms of the agreement, which is subject to the approval of the
relevant authorities, the enterprise value of Aventis CropScience will be
set at around 7.25 billion euros including debt. The transaction is
expected to close during the first quarter of 2002.
"The combined businesses of Aventis CropScience and Bayer will become one
of the leaders in the agricultural industry," said Horst Waesche, member of
the Management Board of Aventis. "We are convinced that strategically,
Bayer will be the best fit for Aventis CropScience."
In November 2000, Aventis announced its intention to divest Aventis
CropScience by the end of 2001 in order to focus on its pharmaceutical
business. After reviewing different divestment options, Aventis has
continued exclusive negotiations with Bayer since mid-July 2001. This
agreement represents a decisive step in the strategic shift of Aventis into
a pure-play pharmaceutical company. For Aventis, the expected decrease in
the net debt - through the proceeds from the divestment as well as the
deconsolidation of debt associated with CropScience - would mean additional
flexibility for the future development of its pharmaceutical business.
Aventis CropScience is a major crop protection company focusing on
researching, developing and marketing innovative solutions that meet the
needs of today's farming: healthy crops, increased yields, improved crop
and food quality.
With 4 billion euros sales in 2000, Aventis CropScience employs about
15,300 people in more than 120 countries worldwide.
Aventis (NYSE: AVE) is dedicated to improving life through the discovery
and development of innovative products. In 2000, Aventis generated group
sales of ? 22.3 billion and employed around 92,500 people in its Pharma and
Agriculture businesses.
Aventis was launched in December 1999 through the merger of Hoechst AG of
Germany and Rhône-Poulenc SA of France. Corporate headquarters are in
Strasbourg, France. For more information, please visit: www.aventis.com
Statements in this news release other than historical information are
forward-looking statements subject to risks and uncertainties. Actual
results could differ materially depending on factors such as the
availability of resources, the timing and effects of regulatory actions,
the strength of competition, the outcome of litigation and the
effectiveness of patent protection. Additional information regarding risks
and uncertainties is set forth in the current Annual Report on Form 20-F
of Aventis on file with the Securities and Exchange Commission. ■
http:\\www.ag168.com| 玉田地有限公司| 電話: 0919278319| 傳真: 02-27644109| rdai@ms1.hinet.net